Captor Therapeutics Spolka Akcyjna (WSE:CTX)
78.90
-0.90 (-1.13%)
May 7, 2026, 10:49 AM CET
WSE:CTX Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 10.72 | 39.26 | 75.7 | 71.04 | 117.94 |
Short-Term Investments | - | - | - | 19.85 | - |
Cash & Short-Term Investments | 10.72 | 39.26 | 75.7 | 90.89 | 117.94 |
Cash Growth | -72.69% | -48.14% | -16.71% | -22.94% | 1007.03% |
Accounts Receivable | 1.22 | 2.95 | 6.37 | 0.98 | 0.97 |
Other Receivables | 0.5 | 35.3 | 6.2 | 8.7 | 10.73 |
Receivables | 1.71 | 38.25 | 12.57 | 9.68 | 11.71 |
Prepaid Expenses | - | 0.11 | 0.09 | 0.07 | 0.06 |
Other Current Assets | 21.39 | 0.47 | 0.29 | 0.68 | 0.85 |
Total Current Assets | 33.82 | 78.09 | 88.65 | 101.32 | 130.56 |
Property, Plant & Equipment | 4.91 | 7.86 | 6.95 | 10.67 | 12.61 |
Other Intangible Assets | 1.18 | 0.42 | 0.31 | 0.6 | 0.18 |
Long-Term Deferred Charges | - | 0.99 | 1.17 | 0.18 | 0.18 |
Other Long-Term Assets | 0.11 | 0.15 | 0.22 | 0.23 | 0.01 |
Total Assets | 40.02 | 87.5 | 97.29 | 113 | 143.54 |
Accounts Payable | 4.39 | 2.65 | 6.5 | 5.65 | 3.19 |
Accrued Expenses | - | 9.34 | 9.41 | 1.48 | 2.25 |
Current Portion of Leases | 2.06 | 2.75 | 2.53 | 3.72 | 5.24 |
Current Income Taxes Payable | - | 1.22 | 0.96 | 1.35 | 0.9 |
Current Unearned Revenue | 7.74 | 2.91 | 7.18 | 0.13 | 0.13 |
Other Current Liabilities | 0.72 | 1.16 | 0.15 | 1.08 | 4.66 |
Total Current Liabilities | 14.91 | 20.03 | 26.73 | 13.39 | 16.37 |
Long-Term Leases | 1.52 | 2.89 | 1.25 | 3.24 | 2.94 |
Pension & Post-Retirement Benefits | 0.12 | 0.1 | 0.1 | 0.05 | 0.03 |
Total Liabilities | 16.54 | 23.02 | 28.07 | 16.68 | 19.34 |
Common Stock | 0.55 | 0.55 | 0.47 | 0.42 | 0.41 |
Additional Paid-In Capital | 240.49 | 240.49 | 208.88 | 170.03 | 170.03 |
Retained Earnings | -245.11 | -203.11 | -164.69 | -94.1 | -58.21 |
Comprehensive Income & Other | 27.54 | 26.54 | 24.56 | 19.98 | 11.97 |
Shareholders' Equity | 23.48 | 64.47 | 69.22 | 96.32 | 124.2 |
Total Liabilities & Equity | 40.02 | 87.5 | 97.29 | 113 | 143.54 |
Total Debt | 3.58 | 5.64 | 3.78 | 6.95 | 8.18 |
Net Cash (Debt) | 7.14 | 33.62 | 71.93 | 83.94 | 109.76 |
Net Cash Growth | -78.75% | -53.26% | -14.31% | -23.53% | - |
Net Cash Per Share | 1.29 | 7.22 | 15.48 | 20.14 | 26.59 |
Filing Date Shares Outstanding | 5.53 | 5.5 | 4.65 | 4.17 | 4.13 |
Total Common Shares Outstanding | 5.53 | 5.5 | 4.65 | 4.17 | 4.13 |
Working Capital | 18.91 | 58.06 | 61.92 | 87.93 | 114.19 |
Book Value Per Share | 4.24 | 11.73 | 14.90 | 23.11 | 30.09 |
Tangible Book Value | 22.3 | 64.06 | 68.91 | 95.72 | 124.02 |
Tangible Book Value Per Share | 4.03 | 11.66 | 14.83 | 22.96 | 30.04 |
Buildings | - | 19.28 | 14.94 | 13.84 | 9.77 |
Machinery | - | 21.15 | 19.92 | 19.61 | 24.85 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.